WF-47-JS03 is a potent and selective RET kinase inhibitor with over 500-fold selectivity over kinase insert domain receptor (VEGFR2/KDR/Flk-1); it exhibits IC50 values of 1.7 nM and 5.3 nM in Ba/F3 cells transfected with KIF5B-RET and LC-2/ad lung cancer cells transfected with CCDC6-RET, respectively; it is capable of penetrating the blood-brain barrier.